Finanza

Notizie Discussioni Tecnici Previsione Stagionalità

EBITDA su SIMCERE PHARMACEUTICAL GRP LTD.

Dati annuali

2018

2019

2020

2021

2022

2023

TTM

‪0,00‬

‪‪400,00 M‬‬

‪‪800,00 M‬‬

‪‪1,20 B‬‬

‪‪1,60 B‬‬

Periodo

Valore

Variazione

Variazione %

TTM

‪‪1,18 B‬‬

+‪‪239,89 M‬‬

+‪25,41‬%

2023

‪‪943,90 M‬‬

+‪‪109,92 M‬‬

+‪13,18‬%

2022

‪‪833,99 M‬‬

+‪‪429,48 M‬‬

+‪106,17‬%

2021

‪‪404,51 M‬‬

‪‪−307,05 M‬‬

‪−43,15‬%

2020

‪‪711,56 M‬‬

‪‪−679,05 M‬‬

‪−48,83‬%

2019

‪‪1,39 B‬‬

+‪‪319,97 M‬‬

+‪29,89‬%

2018

Dati semestrali

H2 '19

H1 '20

H2 '20

H1 '21

H2 '21

H1 '22

H2 '22

H1 '23

H2 '23

H1 '24

‪0,00‬

‪‪200,00 M‬‬

‪‪400,00 M‬‬

‪‪600,00 M‬‬

‪‪800,00 M‬‬

Periodo

Valore

Variazione

Variazione %

H1 '24

‪‪728,68 M‬‬

+‪‪273,57 M‬‬

+‪60,11‬%

H2 '23

‪‪455,11 M‬‬

‪‪−34,61 M‬‬

‪−7,07‬%

H1 '23

‪‪489,72 M‬‬

+‪‪162,30 M‬‬

+‪49,57‬%

H2 '22

‪‪327,42 M‬‬

‪‪−188,32 M‬‬

‪−36,51‬%

H1 '22

H2 '21

H1 '21

H2 '20

H1 '20

H2 '19